Company

Organon Reports Q3 2023 Financials with Mixed Results, Notable Decline in Women’s Health Sales

CompanyDrug

Pfizer Inc. Reports Q3 2023 Revenue Contraction and Launches Cost Realignment Program

CompanyDeals

AstraZeneca Partners with Cellectis for Next-Generation Cell and Gene Therapies

Company

Daiichi Sankyo Reports 19.5% YOY Revenue Growth in First Half of Fiscal 2023

CompanyDrug

EpimAh Biotherapeutics to Present First-in-Human Results for EMB-06 at SITC Annual Meeting

Company

GSK Reports Modest 2% YOY Growth in Q3 2023 Finances, Vaccines Unit Soars 24%

CompanyDeals

We-Linking Secures Angel Financing for Implantable Brain Computer Interface Development

CompanyDrug

Chongqing Precision Biotechnology’s PCAR-19B Receives CDE Nod for Breakthrough Therapy Designation

Company

Astellas Pharma Inc. Reports Moderate Revenue Growth in H1 Fiscal 2023 Financials

CompanyDrug

Sichuan Kelun-Biotech’s SKB264 Receives Priority Review Status for TNBC Treatment in China

CompanyDrug

Hinova Pharmaceuticals’ HP518 Receives NMPA Approval for mCRPC Clinical Trial

CompanyDrug

Sino Biopharmaceutical’s TQG3902 Injection Receives NMPA Approval for Septic Shock Clinical Trial